Advertisement

Topics

Search Results for "Takeda"

07:58 EDT 20th August 2017 | BioPortfolio

Original Source: Takeda Pharmaceuticals International AG Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 24022017] Prices from USD $250

SummaryTakeda Pharmaceuticals International AG Takeda, a subsidiary of Takeda Pharmaceutical Company Ltd is a pharmaceutical company that offers researches, development, manufacturing and marketing of pharmaceutical products. The company offers treatments in respiratory and immunology, central nervous system, cardiovascular and metabolic, cancer, general medicine, and vaccines areas. It also provides services such as contract manufacturing and product development, product packaging and quality control servi...

Matching Channels

Pertussis Vaccine acellular Takeda

The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

Matching News

Takeda announces Takeda-PRA Development Center KK

Takeda Pharmaceutical has entered into an agreement for absorption-type company split with its wholly-owned subsidiary which was established in March 2017 (NewCo) and intends to enter into another agr...

Takeda to Collaborate on IBD Microbiome Therapeutics

NewsFinch Therapeutics and Takeda announce global collaboration to develop microbiome therapeutics in inflammatory bowel disease (IBD). Takeda will make an upfront payment of $10 million to Finch for ...

Takeda lays off more than half of Ariad’s US staff

Takeda acquired Ariad Pharmaceuticals at the beginning on the year for $5.2 billion, a price many thought was relatively high but satisfied Takeda’s well-known desire to bolster its business with an...

Takeda and Abingworth invest $100mm in GammaDelta Therapeutics; Takeda has option to buy

Takeda Pharmaceutical Co. Ltd., through its Millennium Pharmaceuticals/Takeda Oncology unit, and Abingworth agreed to together commit up to $100mm in funding to Abingworth-seeded biotech GammaDelta Th...

Takeda and Shattuck Labs Announce Research Collaboration to Explore Agonist Redirected ...

Takeda Contact:Kelly Schlemm – USAkelly.schlemm@takeda.com+1-617-551-8865orShattuck Contact:Josiah Hornblowerjhornblower@shattucklabs.com Read more...

Takeda options programs discovered through Schrodinger alliance

Takeda Pharmaceutical Co. Ltd. and drug discovery firm Schrodinger Inc. penned a multi-year, multi-target deal focused on Takeda’s core therapy areas.

Nektar and Takeda enter into trial collaboration for myeloma, lymphoma, and colorectal cancer

Nektar Therapeutics and Takeda Pharmaceutical Co. Ltd., through its Takeda Oncology/Millennium Pharmaceuticals division, entered into a trial collaboration to explore the combination of Nektar’s NKT...

Takeda and Molecular Templates Announce Multi-Target Research and...

The collaboration will apply Molecular Templates' engineered toxin bodies technology platform to potential therapeutic targets provided by Takeda through a joint scientific committee of both compa...

Matching PubMed Articles

Video Comment on Kenichi Takeda et al.

Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation.

Bile acids play a critical role in the regulation of glucose, lipid and energy metabolisms by activating the nuclear bile acid receptor farnesoid X receptor (FXR) and membrane G protein-coupled bile a...

Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia and NAFLD.

Bile acids are signaling molecules, which coordinately regulate metabolism and inflammation via the nuclear farnesoid X receptor (FXR) and the Takeda G protein-coupled receptor 5 (TGR5). These recepto...

Limited Transmission Potential of Takeda's Tetravalent Dengue Vaccine Candidate by Aedes albopictus.

Recombinant live-attenuated chimeric tetravalent dengue vaccine viruses, TDV-1, -2, -3, and -4, contain the premembrane and envelope genes of dengue virus serotypes 1-4 in the replicative background o...

TUDCA: An Agonist of the Bile Acid Receptor GPBAR1/TGR5 with Anti-Inflammatory Effects in Microglial Cells.

Bile acids are steroid acids found in the bile of mammals. The bile acid conjugate tauroursodeoxycholic acid (TUDCA) is neuroprotective in different animal models of stroke and neurological diseases. ...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement